Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data.
<h4>Introduction</h4>Gene expression patterns characterizing clinically-relevant molecular subgroups of glioblastoma are difficult to reproduce. We suspect a combination of biological and analytic factors confounds interpretation of glioblastoma expression data. We seek to clarify the na...
Guardado en:
Autores principales: | Nicholas F Marko, John Quackenbush, Robert J Weil |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bcededc8d9224b12b89bd0cfcfb15dc8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?
por: Claire Gazaille, et al.
Publicado: (2021) -
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
por: Sejin Oh, et al.
Publicado: (2020) -
Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated <i>MGMT</i>
por: María del Mar Álvarez-Torres, et al.
Publicado: (2021) -
Hypoxia: The Cornerstone of Glioblastoma
por: Marta Domènech, et al.
Publicado: (2021) -
Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma
por: Andrea Magali González-Mora, et al.
Publicado: (2021)